Cargando…

Serum-Based KRAS(G12/G13) Mutation Detection Using Droplet Digital PCR: Clinical Implications and Limitations in Colorectal Adenocarcinoma With Tumor Heterogeneity

BACKGROUND: Cell-free DNA (cfDNA) has arisen as an alternative target for evaluating somatic mutations in cancer. KRAS mutation status is critical for targeted therapy in colorectal adenocarcinoma (CRAC). We evaluated KRAS(G12/G13) mutations in cfDNA extracted from serum and compared the results wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ju Seok, Bae, Go Eun, Kim, Seok-Hwan, Choi, Min Kyung, Yeo, Min-Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873888/ https://www.ncbi.nlm.nih.gov/pubmed/33585224 http://dx.doi.org/10.3389/fonc.2020.604772

Ejemplares similares

Identification of a Clinical Cutoff Value for Multiplex KRAS(G12/G13) Mutation Detection in Colorectal Adenocarcinoma Patients Using Digital Droplet PCR, and Comparison with Sanger Sequencing and PNA Clamping Assay
por: Lee, Kyung Ha, et al.
Publicado: (2020)

Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR
por: Olmedillas-López, Susana, et al.
Publicado: (2017)

Targeted Sequencing of Ascites and Peritoneal Washing Fluid of Patients With Gastrointestinal Cancers and Their Clinical Applications and Limitations
por: Bae, Go Eun, et al.
Publicado: (2021)

Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer
por: Choi, Jeesoo, et al.
Publicado: (2022)

Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer
por: Michaelidou, Kleita, et al.
Publicado: (2020)

KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients
por: Olmedillas López, Susana, et al.
Publicado: (2016)

Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay
por: Chung, Hee-Jung, et al.
Publicado: (2020)

Concomitant Mutations G12D and G13D on the Exon 2 of the KRAS Gene: Two Cases of Women with Colon Adenocarcinoma
por: De Falco, Elena, et al.
Publicado: (2021)

Micro-injection Molded Droplet Generation System for Digital PCR Application
por: Jo, Daae, et al.
Publicado: (2022)

Structural dataset for the fast-exchanging KRAS G13D
por: Lu, Jia, et al.
Publicado: (2015)

Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
por: Chen, Chih-Chieh, et al.
Publicado: (2013)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR
por: Ahn, Sung Gwe, et al.
Publicado: (2022)

Improvement of digital PCR conditions for direct detection of KRAS mutations
por: Lee, Jina, et al.
Publicado: (2020)

Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice
por: Kim, Kyung-Hee, et al.
Publicado: (2023)

Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA
por: Kim, Sung-Su, et al.
Publicado: (2018)

Comparison of droplet digital PCR and quantitative real-time PCR in mcrA-based methanogen community analysis
por: Kim, Tae Gwan, et al.
Publicado: (2014)

Author Correction: Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR
por: Ahn, Sung Gwe, et al.
Publicado: (2022)

Cytopathologic features of human papillomavirus–independent, gastric-type endocervical adenocarcinoma
por: Yeo, Min-Kyung, et al.
Publicado: (2022)

Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas
por: Pirlog, Radu, et al.
Publicado: (2022)

Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors
por: Goebel, Lisa, et al.
Publicado: (2023)

Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients
por: Yang, In Seok, et al.
Publicado: (2018)

Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection
por: Dong, Lianhua, et al.
Publicado: (2018)

Development of the Droplet Digital PCR Method for the Detection and Quantification of Erwinia pyrifoliae
por: He, Lin, et al.
Publicado: (2023)

Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR
por: Esteva-Socias, Margalida, et al.
Publicado: (2020)

Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR
por: Isaka, Tetsuya, et al.
Publicado: (2021)

Association between Serum Varicella-Zoster Virus IgM and IgG and Prognosis of Ramsay Hunt Syndrome
por: Chung, Seok Hwan, et al.
Publicado: (2023)

Comparison of Real-Time PCR and Droplet Digital PCR for the Quantitative Detection of Lactiplantibacillus plantarum subsp. plantarum
por: Choi, Chang-Hun, et al.
Publicado: (2022)

Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice
por: Kumar, Gaurav, et al.
Publicado: (2021)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014)

Clinical significance of the KRAS G13D mutation in anastomotic recurrence of colorectal cancer
por: Matsunaga, Keigo, et al.
Publicado: (2023)

Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS(G12D) inhibitor efficacy in KRAS(G12D)-mutated colorectal cancer
por: Feng, Juanjuan, et al.
Publicado: (2023)

Decreased Expression of the Polarity Regulatory PAR Complex Predicts Poor Prognosis of the Patients with Colorectal Adenocarcinoma()()
por: Yeo, Min-Kyung, et al.
Publicado: (2017)

Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas
por: Rehkaemper, Jan, et al.
Publicado: (2020)

The Research Progress of Direct KRAS G12C Mutation Inhibitors
por: Yang, Ai, et al.
Publicado: (2021)

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016)

Dual Inhibition of KRAS(G12D) and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma
por: Gulay, Kevin Christian Montecillo, et al.
Publicado: (2023)

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach
por: Pender, Alexandra, et al.
Publicado: (2015)

Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2021)

A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors
por: McFall, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bcm3pg1ejffi9d47i8prfct431